At 5 years, mortality did not differ between lobectomy and total thyroidectomy (relative risk [RR], 0.30; 95% CI, 0.07-1.35), and mortality outcomes remained similar between both approaches even after ...
In an interview with Medscape, Manisha H. Shah, MD, a medical oncologist in the Department of Internal Medicine at the Ohio State University Comprehensive Cancer Center, discussed the genetic risk ...
Selpercatinib is approved for several therapeutic indications, including as monotherapy for the treatment of advanced RET-mutant medullary thyroid cancer in the first line. The drug blocks an enzyme ...
TAMPA, Fla., Feb. 10, 2026 /PRNewswire/ -- With the rapid rise in use of GLP-1 receptor agonist medications such as Ozempic®, Wegovy®, and Mounjaro® for diabetes and weight loss, public concern has ...
Thyroid cancer represents the most common endocrine malignancy, and its genetic underpinnings are increasingly being elucidated through advanced genomic methodologies. Research in this area has ...
BOSTON RED SOX PLAYER. MIKE GREENWELL, NOW 62 YEARS OLD AND LIVING IN FLORIDA, SAYS HE’S BEEN DIAGNOSED WITH MEDULLARY THYROID CANCER. GREENWELL BECAME A FAN FAVORITE IN 1988 AFTER REPLACING HALL OF ...
UAB professor Sadanandan Velu, Ph.D., is leading the potential discovery of a new therapeutic strategy that could address a critical need for patients fighting a rare and aggressive form of thyroid ...
Medullary thyroid carcinoma (MTC) is a neuroendocrine tumor with high rates of delta-like ligand 3 (DLL3) expression. MTC has limited treatment options after failure of kinase inhibition.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results